July 13, 2010
The FDA has updated the Boxed Warning of Arava (leflunomide, from sanofi aventis) to highlight the risk of severe liver injury in patients using this drug and how this risk may be reduced.
June 17, 2010
Horizon Pharma announced that data from its Phase 3 study of Lodotra showed a statistically significant improvement in American College of Rheumatology (ACR) response criteria in patients with rheumatoid arthritis (RA).
June 16, 2010
Horizon Pharma announced positive results from its Phase 3 registration study of Lodotra (prednisone tablet), that showed a statistically significant improvement in American College of Rheumatology (ACR) response criteria in patients with rheumatoid arthritis (RA).
May 26, 2010
Horizon Pharma announced that its New Drug Application (NDA) for Duexa was accepted by the FDA for the reduction of the risk of development of upper gastrointestinal ulcers in patients with arthritis and pain.
May 24, 2010
Hisamitsu announced the launch of Salonpas Pain Relief Patch (10% methyl salicylate and 3% I-menthol) and Salonpas Arthritis Pain patch (10% methyl salicylate and 3% I-menthol) for the temporary relief of mild to moderate aches and pains of the muscles and joints associated with arthritis, sprains, strains, bruises and simple backaches experienced by patients age ≥18 years.